论文信息 - IDO production, adaptive immunity, and CTL killing

IDO production, adaptive immunity, and CTL killing

Comment on Braun et al, page [2375][1], and comment on Potula et al, page [2382][2] Indoleamine 2,3-dioxygenase, an enzyme induced in antigen-presenting cells by specific proinflammatory mediators such as prostaglandin E2 (PGE2) or viral infection, can inactivate specific T-cell functions.

T. Luft | E. Maraskovsky | M. Schnurr

[1] B. Baban,et al. GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase. , 2005, Immunity.

[2] G. Opelz,et al. Regulation of human auto- and alloreactive T cells by indoleamine 2,3-dioxygenase (IDO)-producing dendritic cells: too much ado about IDO? , 2005, Blood.

[3] P. Puccetti,et al. A Crucial Role for Tryptophan Catabolism at the Host/Candida albicans Interface1 , 2005, The Journal of Immunology.

[4] J. Cebon,et al. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. , 2005, Blood.

[5] D. Munn,et al. Ido expression by dendritic cells: tolerance and tryptophan catabolism , 2004, Nature Reviews Immunology.

[6] R. Förster,et al. Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. , 2002, Blood.

[7] T. Luft,et al. Functionally distinct dendritic cell (DC) populations induced by physiologic stimuli: prostaglandin E(2) regulates the migratory capacity of specific DC subsets. , 2002, Blood.

[8] F. Di Virgilio,et al. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory properties of mature cells and show a reduced capacity to attract type 1 T lymphocytes. , 2002, Blood.